Stimulating natural immunity to treat cancer
Biomune, Inc. is a privately-held corporation with exclusive patents on compounds that we developed. Our compounds have been shown to be effective in laboratory studies:
- 100% remission of melanoma, lymphoma, and fibrosarcoma cancer in 98% of laboratory animals.
We are excited about these results! Our plan is to:
- Conduct more studies in larger groups of laboratory animals;
- Expand our research to include other forms of cancer;
- Extend our work to clinical trials in humans;
- Obtain FDA approval to treat cancer in people.